Search research articles
Contact Us
Filters
Showing results (151-160 of 188) with videos related to
Page
of 19
Sort By:
Cerebrovascular Diseases Extra
|
January 27, 2017
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery Stenting
Paola Maggio, Claudia Altamura, Domenico Lupoi, et al.
Neurology and Therapy
|
February 8, 2024
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)
Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, et al.
Sleep Medicine
|
March 22, 2024
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study
Giovanna Viticchi, Vincenzo Di Stefano, Claudia Altamura, et al.
Neurology
|
March 26, 2026
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial
Rigmor Højland Jensen, Christofer Lundqvist, Henrik W Schytz, et al.
Neurology
|
September 14, 2014
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease
Matthias Reinhard, Guido Schwarzer, Matthias Briel, et al.
Cephalalgia : an International Journal of Headache
|
May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial
Stewart J Tepper, Henrik W Schytz, Rigmor H Jensen, et al.
The Journal of Headache and Pain
|
June 13, 2026
Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial
Henrik W Schytz, Rigmor H Jensen, Christofer Lundqvist, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 27, 2020
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)
Fabrizio Vernieri, Claudia Altamura, Cinzia Aurilia, et al.
The European Journal of Neuroscience
|
July 6, 2007
Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease
Claudio Babiloni, Emanuele Cassetta, Giuliano Binetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy
Piero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 188) with videos related to
Sort By:
Page
of 19
Cerebrovascular Diseases Extra
|
January 27, 2017
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery Stenting
Paola Maggio, Claudia Altamura, Domenico Lupoi, et al.
Neurology and Therapy
|
February 8, 2024
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)
Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, et al.
Sleep Medicine
|
March 22, 2024
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study
Giovanna Viticchi, Vincenzo Di Stefano, Claudia Altamura, et al.
Neurology
|
March 26, 2026
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial
Rigmor Højland Jensen, Christofer Lundqvist, Henrik W Schytz, et al.
Neurology
|
September 14, 2014
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease
Matthias Reinhard, Guido Schwarzer, Matthias Briel, et al.
Cephalalgia : an International Journal of Headache
|
May 16, 2026
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial
Stewart J Tepper, Henrik W Schytz, Rigmor H Jensen, et al.
The Journal of Headache and Pain
|
June 13, 2026
Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial
Henrik W Schytz, Rigmor H Jensen, Christofer Lundqvist, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 27, 2020
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)
Fabrizio Vernieri, Claudia Altamura, Cinzia Aurilia, et al.
The European Journal of Neuroscience
|
July 6, 2007
Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease
Claudio Babiloni, Emanuele Cassetta, Giuliano Binetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in Italy
Piero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.
Page
of 19